Next Generation Fat Burners

Technology long-term tends to move in the direction of progressive evolution, not just in the fields of computer technology and biotech, but also in virtually all other fields, inclusive of nutriceuticals. Fat burners since their inception have always used caffeine as the base constituent of central nervous system (CNS) stimulation. Different formulas have sought to methodically build around caffeine over many decades. The most popular stack to date was the ECA stack (Ephedrine, Caffeine, and Aspirin), which caused extraordinary levels of fat loss in compressed periods of time for a wide variety of users. Even those who were genetically stubborn, in terms of fat loss benefited from this stack. But the stack had huge trade-offs concerning health risks. Advocates get defensive about the ephedrine ban stating that those who died took too much, but that does not address the point: Long-term use of ephedrine will cause intensified vaso-constriction, thus elevating blood pressure beyond acceptable levels. This is really what contributed to the string of heart attacks that led the FDA to initially ban its use. I believe that ephedrine like any other supplements should have its use responsibly managed, given a certain level of risk, in which the user incurs by commitment.

The new era of fat burners has produced products that can act directly on fat receptors without much CNS stimulation. Therefore users will get a similar quality of fat burning compared to the aforementioned ECA stack, but without its, again stimulatory effects. Substances such as octopamine, evodiamine, hordinene, alpha-yohimbine, tyramine, etc. act on the receptors (i.e., B3 fat receptors), preserve neurotransmission output and recycle metabolic by-products to reinforce the fat burning process, at the cellular level. These and other receptor specific substances are now used in a wide array of formulas, which have the built-in incentive of relying less on caffeine. But here's the caveat for supplement manufacturers and marketers: The market association of caffeine with CNS-based stimulatory fat burning is so strong that not having caffeine or some other mexylxanthine would most likely nullify the above incentive not to use it. As a matter of fact, it would create a disincentive for manufacturers that wish to compete in the market for fat burners. In the end, users have more options regarding the use of caffeine when supplementing with these next generation fat burners, while marketers have the opportunity to design formulas for segments of the fat burner market based on preference for caffeine and/or other non-stimulants.


Recommended Product(s):

BSN Thermonex Fat Burner

R-Alpha Lipoic Acid

Chromium Picolinate


Digg This! | Add to Del.icio.us | Furl It

Add to: